[Clinical trials of a new antifungal agent in epidermomycoses. (Lauryl-oxy-propyl-amino-butyric acid associated with benzalkonium chloride in acid aqueous solution)].
D000293:Adolescent; D000328:Adult; D000613:Aminobutyrates / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000613:Aminobutyrates; D000935:Antifungal Agents; D001548:Benzalkonium Compounds
Essais en clinique d'un nouvel antifongique dans les epidermomycoses. (Acide lauryl-oxy-propyl-amino-butyrique associé au chlorure de benzalkonium, en solution aqueuse acide)